المؤلفون: Qualls DA; Lymphoma Service, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY., Lambert N; Department of Medicine, Baylor College of Medicine, Houston, TX., Caimi PF; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH., Merrill M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Pullarkat P; Division of Hematology-Oncology, Massachusetts General Hospital, Boston, MA., Godby RC; Hematology Division, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Bond DA; Division of Hematology, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH., Wehmeyer GT; Department of Medicine, Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY., Romancik J; Department of Hematology and Medical Oncology, Winship Cancer Institute at Emory University, Atlanta, GA., Amoozgar B; Department of Medicine, Washington University School of Medicine, St Louis, MO., Leslie L; Lymphoma Division, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ., Nastoupil LJ; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Crombie JL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Abramson JS; Division of Hematology-Oncology, Massachusetts General Hospital, Boston, MA., Khurana A; Hematology Division, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Nowakowski GS; Hematology Division, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Maddocks K; Division of Hematology, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH., Rutherford SC; Department of Medicine, Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY., Kahl B; Department of Medicine, Washington University School of Medicine, St Louis, MO., Okwali M; Lymphoma Service, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY., Buege MJ; Lymphoma Service, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY., Seshan V; Lymphoma Service, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY., Batlevi CL; Lymphoma Service, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY., Salles G; Lymphoma Service, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY.; Weill Cornell Medical College, New York, NY.

المصدر: Blood [Blood] 2023 Dec 28; Vol. 142 (26), pp. 2327-2331.

نوع المنشور: Multicenter Study; Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, Large B-Cell, Diffuse*/drug therapy, Humans ; Lenalidomide/therapeutic use ; Treatment Outcome ; Retrospective Studies ; Antineoplastic Combined Chemotherapy Protocols/adverse effects

المؤلفون: Villa D; British Columbia Cancer Centre for Lymphoid Cancer and University of British Columbia, Vancouver, BC, Canada., Jiang A; British Columbia Cancer Centre for Lymphoid Cancer and University of British Columbia, Vancouver, BC, Canada., Visco C; Department of Medicine, Section of Hematology, University of Verona, Verona, Italy., Crosbie N; Haematology, University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom., McCulloch R; Department of Haematology, Gloucestershire Hospitals NHS Foundation Trust, Gloucester, United Kingdom., Buege MJ; Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY.; University of Illinois Chicago College of Pharmacy, Chicago, IL., Kumar A; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Bond DA; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH., Paludo J; Division of Hematology, Mayo Clinic, Rochester, MN., Maurer MJ; Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, MN., Thanarajasingam G; Division of Hematology, Mayo Clinic, Rochester, MN., Lewis KL; Department of Haematology, Sir Charles Gairdner Hospital, Perth, WA, Australia.; Division of Internal Medicine, Medical School, University of Western Australia, Perth, WA, Australia., Cheah CY; Department of Haematology, Sir Charles Gairdner Hospital, Perth, WA, Australia.; Division of Internal Medicine, Medical School, University of Western Australia, Perth, WA, Australia., Baech J; Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Haematology, Aalborg, Denmark., El-Galaly TC; Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Haematology, Aalborg, Denmark., Kugathasan L; Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada., Scott DW; British Columbia Cancer Centre for Lymphoid Cancer and University of British Columbia, Vancouver, BC, Canada., Gerrie AS; British Columbia Cancer Centre for Lymphoid Cancer and University of British Columbia, Vancouver, BC, Canada., Lewis D; Haematology, University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom.

المصدر: Blood advances [Blood Adv] 2023 Aug 22; Vol. 7 (16), pp. 4576-4585.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, Mantle-Cell*/pathology , Hematopoietic Stem Cell Transplantation*, Adult ; Humans ; Ki-67 Antigen ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Prognosis

المؤلفون: Buege MJ; Department of Pharmacy, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York, 10018, USA.; Department of Pharmacy Practice, University of Illinois-Chicago College of Pharmacy, 833 S Wood Street, Chicago, Illinois, 60605, USA., Drill E; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York, 10018, USA., Horwitz SM; Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York, 10018, USA., LeVoir A; Department of Pharmacy, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York, 10018, USA., Pak T; Department of Pharmacy, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York, 10018, USA., Peterson TJ; Department of Pharmacy, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York, 10018, USA., Dao PH; Department of Pharmacy, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York, 10018, USA., Matasar MJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York, 10018, USA.

المصدر: European journal of haematology [Eur J Haematol] 2023 Jul; Vol. 111 (1), pp. 96-102. Date of Electronic Publication: 2023 Apr 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609 (Electronic) Linking ISSN: 09024441 NLM ISO Abbreviation: Eur J Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, Non-Hodgkin*/drug therapy , Lymphoma, Non-Hodgkin*/complications , Heart Failure*/chemically induced , Heart Failure*/epidemiology , Heart Failure*/complications , Ventricular Dysfunction, Left*/chemically induced , Ventricular Dysfunction, Left*/complications, Adult ; Humans ; Retrospective Studies ; Incidence ; Cardiotoxicity/epidemiology ; Cardiotoxicity/etiology ; Antibiotics, Antineoplastic/therapeutic use ; Anthracyclines/adverse effects

المؤلفون: Pak TK; Department of Pharmacy, New York, NY, USA., Dixon BN; Department of Pharmacy, New York, NY, USA., Buege MJ; Department of Pharmacy, New York, NY, USA., Dao PH; Department of Pharmacy, New York, NY, USA., Leary MH; Nursing, New York, NY, USA., Jarrett JC; Nursing, New York, NY, USA., Duggan TA; Medicine, Memorial Sloan Kettering Cancer Center New York, New York, NY, USA., Caron P; Medicine, Memorial Sloan Kettering Cancer Center New York, New York, NY, USA.; Department of Medicine Weill Cornell Medical College, New York, NY, USA., Falchi L; Medicine, Memorial Sloan Kettering Cancer Center New York, New York, NY, USA.; Department of Medicine Weill Cornell Medical College, New York, NY, USA., Hamlin P; Medicine, Memorial Sloan Kettering Cancer Center New York, New York, NY, USA.; Department of Medicine Weill Cornell Medical College, New York, NY, USA., Hamilton A; Medicine, Memorial Sloan Kettering Cancer Center New York, New York, NY, USA., Matasar MJ; Medicine, Memorial Sloan Kettering Cancer Center New York, New York, NY, USA.; Department of Medicine Weill Cornell Medical College, New York, NY, USA., Moskowitz A; Medicine, Memorial Sloan Kettering Cancer Center New York, New York, NY, USA.; Department of Medicine Weill Cornell Medical College, New York, NY, USA., Noy A; Medicine, Memorial Sloan Kettering Cancer Center New York, New York, NY, USA.; Department of Medicine Weill Cornell Medical College, New York, NY, USA., Owens CN; Medicine, Memorial Sloan Kettering Cancer Center New York, New York, NY, USA., Von Keudell G; Medicine, Memorial Sloan Kettering Cancer Center New York, New York, NY, USA.; Department of Medicine Weill Cornell Medical College, New York, NY, USA., Younes A; Medicine, Memorial Sloan Kettering Cancer Center New York, New York, NY, USA., Zelenetz AD; Medicine, Memorial Sloan Kettering Cancer Center New York, New York, NY, USA.; Department of Medicine Weill Cornell Medical College, New York, NY, USA., Kumar A; Medicine, Memorial Sloan Kettering Cancer Center New York, New York, NY, USA.; Department of Medicine Weill Cornell Medical College, New York, NY, USA.

المصدر: Leukemia & lymphoma [Leuk Lymphoma] 2022 Apr; Vol. 63 (4), pp. 876-884. Date of Electronic Publication: 2021 Nov 16.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

مواضيع طبية MeSH: Cytarabine* , Lymphoma*/drug therapy, Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Dexamethasone ; Humans ; Outpatients ; Oxaliplatin ; Rituximab

المؤلفون: Buege MJ; Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY. Electronic address: buegem@mskcc.org., Dao PH; Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY., Drill E; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., LeVoir A; Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY., Pak T; Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY., Peterson TJ; Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY., Straus DJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.

المصدر: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2021 Dec; Vol. 21 (12), pp. 873-878. Date of Electronic Publication: 2021 Jul 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE

مواضيع طبية MeSH: Burkitt Lymphoma* , Lymphoma, Large B-Cell, Diffuse*/pathology, Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Humans ; Neoplasm Recurrence, Local/drug therapy ; Rituximab/therapeutic use ; Treatment Outcome

المؤلفون: Yerram P; Department of Pharmacy, 5803Memorial Sloan Kettering Cancer Center, New York, NY, USA., Thackray J; Department of Pharmacy, 5803Memorial Sloan Kettering Cancer Center, New York, NY, USA., Modelevsky LR; Department of Pharmacy, 5803Memorial Sloan Kettering Cancer Center, New York, NY, USA., Land JD; Department of Pharmacy, 5803Memorial Sloan Kettering Cancer Center, New York, NY, USA., Reiss SN; Department of Pharmacy, 5803Memorial Sloan Kettering Cancer Center, New York, NY, USA., Spatz KH; Department of Pharmacy, 5803Memorial Sloan Kettering Cancer Center, New York, NY, USA., Levoir AC; Department of Pharmacy, 5803Memorial Sloan Kettering Cancer Center, New York, NY, USA., Pak TK; Department of Pharmacy, 5803Memorial Sloan Kettering Cancer Center, New York, NY, USA., Dao PH; Department of Pharmacy, 5803Memorial Sloan Kettering Cancer Center, New York, NY, USA., Buege MJ; Department of Pharmacy, 5803Memorial Sloan Kettering Cancer Center, New York, NY, USA., Derespiris LM; Department of Pharmacy, 5803Memorial Sloan Kettering Cancer Center, New York, NY, USA., Lau C; Department of Pharmacy, 5803Memorial Sloan Kettering Cancer Center, New York, NY, USA., Orozco JS; Department of Pharmacy, 5803Memorial Sloan Kettering Cancer Center, New York, NY, USA., Boparai M; Department of Pharmacy, 5803Memorial Sloan Kettering Cancer Center, New York, NY, USA., Koranteng LA; Department of Pharmacy, 5803Memorial Sloan Kettering Cancer Center, New York, NY, USA., Reichert KE; Department of Pharmacy, 5803Memorial Sloan Kettering Cancer Center, New York, NY, USA., Yan SQ; Department of Pharmacy, 5803Memorial Sloan Kettering Cancer Center, New York, NY, USA., Daukshus NP; Department of Pharmacy, 5803Memorial Sloan Kettering Cancer Center, New York, NY, USA., Mathew S; Department of Pharmacy, 5803Memorial Sloan Kettering Cancer Center, New York, NY, USA., Buie LW; Department of Pharmacy, 5803Memorial Sloan Kettering Cancer Center, New York, NY, USA., Tizon RF; Department of Pharmacy, 5803Memorial Sloan Kettering Cancer Center, New York, NY, USA., Freeswick S; Department of Pharmacy, 5803Memorial Sloan Kettering Cancer Center, New York, NY, USA., Liu D; Department of Pharmacy, 5803Memorial Sloan Kettering Cancer Center, New York, NY, USA., Harnicar S; Department of Pharmacy, 5803Memorial Sloan Kettering Cancer Center, New York, NY, USA.

المصدر: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2021 Mar; Vol. 27 (2), pp. 389-394. Date of Electronic Publication: 2021 Jan 17.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-092X (Electronic) Linking ISSN: 10781552 NLM ISO Abbreviation: J Oncol Pharm Pract Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19*/therapy , Pandemics*, Ambulatory Care Facilities/*organization & administration , Cancer Care Facilities/*organization & administration , Neoplasms/*therapy , Pharmacy Service, Hospital/*organization & administration, Humans ; New York City ; Patient Care ; Pharmacists ; Professional Role ; Retrospective Studies ; Telemedicine

المؤلفون: Buege MJ; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Kumar A; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Dixon BN; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Tang LA; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Pak T; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Orozco J; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Peterson TJ; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Maples KT; Memorial Sloan Kettering Cancer Center, New York, NY, USA.

المصدر: The Annals of pharmacotherapy [Ann Pharmacother] 2020 Sep; Vol. 54 (9), pp. 879-898. Date of Electronic Publication: 2020 Feb 20.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Sage Country of Publication: United States NLM ID: 9203131 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1542-6270 (Electronic) Linking ISSN: 10600280 NLM ISO Abbreviation: Ann Pharmacother Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoietic Stem Cell Transplantation*, Antineoplastic Combined Chemotherapy Protocols/*administration & dosage , Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Lymphoma, Mantle-Cell/*drug therapy, Administration, Oral ; Adult ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Humans ; Lymphoma, Mantle-Cell/pathology ; Male ; Middle Aged ; Treatment Outcome

المؤلفون: Buege MJ; Department of Pharmacy, Memorial Sloan Kettering Cancer Center, 1275 York Ave, S710, New York, NY, United States. Electronic address: buegem@mskcc.org., Do B; Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Lee HC; Departments of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Weber DM; Departments of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Horowitz SB; Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Feng L; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Qing Y; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Shank BR; Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

المصدر: Cancer treatment and research communications [Cancer Treat Res Commun] 2019; Vol. 21, pp. 100159. Date of Electronic Publication: 2019 Sep 05.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 101694651 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2468-2942 (Electronic) Linking ISSN: 24682942 NLM ISO Abbreviation: Cancer Treat Res Commun Subsets: MEDLINE

مواضيع طبية MeSH: Calcium/*blood , Hypercalcemia/*blood , Multiple Myeloma/*blood, Aged ; Breast Neoplasms/blood ; Carcinoma, Non-Small-Cell Lung/blood ; Female ; Humans ; Lung Neoplasms/blood ; Male ; Middle Aged

المؤلفون: Buege MJ; Pharmacy Clinical Programs, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. mjbuege@mdanderson.org., DiPippo AJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. ajdipippo@mdanderson.org., DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. CDiNardo@mdanderson.org.

المصدر: Cancers [Cancers (Basel)] 2018 Jun 06; Vol. 10 (6). Date of Electronic Publication: 2018 Jun 06.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

المؤلفون: Buege MJ; Division of Pharmacy, University of Texas MD Anderson Cancer Center, Houston, TX., Brown JE; Department of Pharmacy, University of Rochester Medical Center, Rochester, NY.; Wegmans School of Pharmacy at St. John Fisher College, Rochester, NY., Aitken SL; Division of Pharmacy, University of Texas MD Anderson Cancer Center, Houston, TX slaitken@mdanderson.org.; Center for Antimicrobial Resistance and Microbial Genomics, UTHealth McGovern Medical School, Houston, TX. slaitken@mdanderson.org.

المصدر: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2017 Jun 15; Vol. 74 (12), pp. 875-887. Date of Electronic Publication: 2017 Apr 21.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 9503023 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-2900 (Electronic) Linking ISSN: 10792082 NLM ISO Abbreviation: Am J Health Syst Pharm Subsets: MEDLINE

مواضيع طبية MeSH: Anti-Bacterial Agents/*therapeutic use , Drug Approval/*methods , Drug Resistance, Bacterial/*drug effects , Macrolides/*therapeutic use , Pneumonia, Bacterial/*drug therapy , Triazoles/*therapeutic use, Animals ; Anti-Bacterial Agents/adverse effects ; Anti-Bacterial Agents/pharmacokinetics ; Chemical and Drug Induced Liver Injury/epidemiology ; Chemical and Drug Induced Liver Injury/metabolism ; Community-Acquired Infections/drug therapy ; Community-Acquired Infections/epidemiology ; Community-Acquired Infections/metabolism ; Drug Resistance, Bacterial/physiology ; Humans ; Ketolides/adverse effects ; Ketolides/pharmacokinetics ; Ketolides/therapeutic use ; Macrolides/adverse effects ; Macrolides/pharmacokinetics ; Microbial Sensitivity Tests/methods ; Pneumonia, Bacterial/epidemiology ; Pneumonia, Bacterial/metabolism ; Triazoles/adverse effects ; Triazoles/pharmacokinetics ; United States/epidemiology ; United States Food and Drug Administration/standards